Latanoprost NDC 70069-421

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-421Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0421Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-421-01	70069042101	1 BOTTLE in 1 CARTON (70069-421-01) / 2.5 mL in 1 BOTTLEMarketed from Dec 3, 2019
70069-421-03	70069042103	3 BOTTLE in 1 CARTON (70069-421-03) / 2.5 mL in 1 BOTTLEMarketed from Dec 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Latanoprost
Generic name (nonproprietary): latanoprost
Active ingredients: Latanoprost — 50 ug/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Somerset Therapeutics, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201786
Marketing start: Dec 3, 2019
Listing expires: Dec 31, 2027
Identifiers: Product ID 70069-421_836e9c6e-15a0-41bd-b3bb-bd864a5fd1bdSPL ID 836e9c6e-15a0-41bd-b3bb-bd864a5fd1bdSPL set ID 5d0b99ad-f05a-44c7-ac61-26b5a533ea8dRxCUI 314072UNII 6Z5B6HVF6OUPC 0370069421017, 0370069421031

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470069042101 followed by a unit qualifier and the quantity

Package 70069-0421-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 22, 2025.

Indications (excerpt from the label)

Latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Latanoprost ophthalmic solution is a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201786

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201786
Product	Strength	Form · route	Labeler	Product NDC
Latanoprost	Latanoprost 50 ug/mL	Solution/ dropsOphthalmic	NuCare Pharmaceuticals,Inc.	68071-2376